Sort   by:  
 Page size 
The resistance of CML leukemic stem cells (LSC) to tyrosine kinase inhibitor therapies targeting BCR-ABL leads to persistence of disease in most cases. We have identified novel putative therapeutic targets that are differentially expressed in CML LSCs compared to normal hematopoietic stem cells (HS...
ORGANISM(S): Homo sapiens 
Background: BCR-ABL1-like, or Ph-like acute lymphoblastic leukemia is characterized by a gene expression profile similar to BCR-ABL1 positive ALL, genetic alterations of lymphoid transcription factor genes, and poor outcome. Sequencing of small numbers of Ph-like ALL cases has identified genetic alt...
DATA FILES FOR SJPhLike-RNASeq
PCGP Ph-likeALL SNP6
DATA FILES FOR Ph-likeALL WES
WGS DATA FILES FOR SJPhLike
PCGP Ph-likeALL GEA
Sort   by:  
 Page size